January 29th 2024
Ophthalmologist shares pearls from recent roundtable discussion on topic.
November 22nd 2023
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
View More
(CME Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease
View More
(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease
View More
(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease
View More
(CME Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment
View More
(COPE Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment
View More
(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease
View More
18th Annual Controversies in Modern Eye Care
May 4, 2024
Register Now!
Headed to ARVO? You’re invited to dinner COPE CE/CME. Or join virtually!
May 6 & 7, 2024
Register Now!
(COPE Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(CME Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
2nd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
May 18-19, 2024
Register Now!
(COPE Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
(CME Credit) Virtual Case Studies™ in Cataract Surgery: Selecting Surgical Techniques and Preventing Intra-Operative Complications
View More
(COPE Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
Neurotrophic Keratitis Management: How Early Intervention Can Make a Difference
View More
(CME Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
17th Annual Controversies in Modern Eye Care
View More
Thyroid Eye Disease: The Masquerading Eye Disorder—A Guide to Collaborative Care and Accurate Diagnosis
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(COPE Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(COPE Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(CME Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
What’s New in MGD Beyond Heating and Squeezing?
View More
The Ins and Outs of Lubricating Eye Drops
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Expert Perspectives in Diabetic Macular Edema – Considering Pathogenesis & Inflammation in Treatment Selection
View More
Clinical focus for incontinentia pigmenti requires redirection
December 1st 2004Coronado Island, CA-The focus of attention in caring for babies with incontinentia pigmenti (IP) should be on the potential for rapid development of irreversible blindness rather than on the clinically obvious skin manifestations, said Morton F. Goldberg, MD, in the Gertrude D. Pyron Award Lecture at the annual meeting of the American Society of Retina Specialists.
Read More
Aqueous misdirection is complication of intraocular surgery
November 1st 2004New York-Aqueous misdirection is "a rare, but serious complication of intraocular surgery" that requires immediate attention to prevent lasting damage, Celso Tello, MD, told participants at the Glaucoma 2004 meeting here.
Read More
Subconjunctival fibrosis one cause of failed glaucoma filter
October 15th 2004New York -Five potential causes of failure of glaucoma filtration surgery include excessive subconjunctival fibrosis, tight scleral flap sutures, encapsulated bleb, occluded internal ostium, and intraocular obstruction, according to James C. Tsai, MD.
Read More
Aggressive treatment often needed for hypotony maculopathy
October 1st 2004New York-Hypotony maculopathy-damage to the macula caused by clinically significant low IOP-has several causes, including overfiltering blebs, bleb leak, cyclodialysis cleft, and ciliary body effusion/detachment, reported Celso Tello, MD, at the Glaucoma 2004 meeting here.
Read More
Lasker Award lauds Dr. Kelman for medical innovation
October 1st 2004New York-The 2004 Albert Lasker Award for Clinical Medical Research, given posthumously, honors Charles D. Kelman, MD, for transforming cataract surgery "from a risky and lengthy ordeal (2-week hospital stay) into a safe and quick outpatient procedure that has spared millions of people throughout the world from blindness," as well as for inspiring similar advances in a number of other medical specialties.
Read More
Lasker Award lauds Dr. Kelman for medical innovation
October 1st 2004New York-The 2004 Albert Lasker Award for Clinical Medical Research, given posthumously, honors Charles D. Kelman, MD, for transforming cataract surgery "from a risky and lengthy ordeal (2-week hospital stay) into a safe and quick outpatient procedure that has spared millions of people throughout the world from blindness," as well as for inspiring similar advances in a number of other medical specialties.
Read More
Ophthalmic community celebrates Dr. Kelman's life
October 1st 2004New York-It is not usual for a memorial ceremony to be punctuated by roars of laughter, but the commemoration held here on Sept. 13 for Charles D. Kelman, MD, was as unusual as the man himself. The tribute was as full of the liveliness, enthusiasm, and love that he expressed for everything in his life-from saxophone playing to song composing to helicopter piloting and to his medical and scientific studying that revolutionized ophthalmology.
Read More
Nidek introduces auto-refractometer-keratometer-tonometer
September 17th 2004Nidek Co., Gamagori, Japan, has introduced the NIDEK RKT-7700-an all-in-one auto-refractometer, keratometer, and tonometer unit-at the European Society of Cataract and Refractive Surgeons meeting in Paris. The new unit brings together advanced and innovative technologies and solutions into one diagnostic platform, offering the first combination unit of its type in the industry, the company reported.
Read More
Verteporfin developer honored for research
September 15th 2004Vancouver, British Columbia-A research chemist from QLT Inc. who helped develop the verteporfin for injection (Visudyne, QLT/Novartis Ophthalmics) treatment for age-related macular degeneration is among 13 chemists from four companies who have been named Heroes of Chemistry by the American Chemical Society.
Read More
Functional damage is key to monitoring glaucoma
August 15th 2004New York-The ideal monitor of glaucoma progression should have high sensitivity, high specificity, be resistant to fluctuations of the condition, require few confirmatory tests, have broad sensitivity at all stages of the disease, and be easy to interpret, according to David S. Greenfield, MD, who spoke at the Glaucoma 2004 meeting here.
Read More
Surgeons set sights on agenda of Current Concepts meeting
February 1st 2004Dorado, Puerto Rico-The 26th annual "Current Concepts in Ophthalmology" meeting, sponsored by Johns Hopkins University School of Medicine/Wilmer Eye Institute and supported by Ophthalmology Times, will be held Feb. 20 to 23 at the Hyatt Dorado Beach Resort.
Read More
Optic disc abnormality predictive of future visual-field loss
August 1st 2003Fort Lauderdale, FL-Both Heidelberg Retina Tomograph (HRT, Heidelberg Engineering) exams and stereoscopic optic disc photographs can show abnormalities that pre- dict glaucomatous visual-field abnormalities as early as 4 years before visual-field conversion occurs, according to results of an analysis conducted at the University of California San Diego, La Jolla.
Read More
Detection of glaucoma progression critical
August 1st 2003Fort Lauderdale, FL-What constitutes glaucoma progression and the relationship between progressive structural and functional injury? These were the main questions researchers set out to answer during a glaucoma mini-symposium at the annual meeting of the Association for Research in Vision and Ophthalmology.
Read More
Retinal thickness analyzer gives more precise information
June 1st 2003Dayton, OH-Move over a few disc diameters from the optic nerve head to assess the retinal thickness in the para-macular region for early diagnosis and close monitoring of the glaucomatous process. That's the message of Talia Technology Inc., Tampa.
Read More
Transition begins after Pfizer-Pharmacia merger
June 1st 2003New York-Pfizer Inc. will invest $400 million to expand its New Jersey facilities and potentially add 1,300 jobs, but plans to close five research and development sites around the world-including two in the United States- and other former Pharmacia Corp. offices as it begins the difficult logistical transition of its $57 billion takeover.
Read More
HLA-B27-associated anterior uveitis a common presentation
June 1st 2003Editor's Note: Anterior uveitis is the most common type of intraocular inflammation. Among patients with inflammation localized primarily to the anterior chamber, 50% or more are HLA-B27 positive. Inaddition, a number of these patients with HLA-B27-associated anterior uveitis have, or will develop, an associated systemicdisorder such as ankylosing spondylitis,reactive arthritis (formerly known asReiter's syndrome), inflammatory bowel disease, or psoriatic arthritis.
Read More
CA-The FDA approval of gatifloxacin ophthalmic solution 0.3% (Zymar, Allergan) marks a milestone as the first fourth-generation fluoroquinolone to enter the ophthalmic market. The therapy for the treatment of bacterial conjunctivitis caused by susceptible strains of bacteria also has a unique mechanism to prevent development of antibiotic resistance, according to Allergan.
Read More